Key Market Indicators
Sales of Spanish blood and blood forming organs medicines are forecast to reach $2.7 billion by 2026, up from $2.1 billion in 2021. This implies an annual growth rate of 3.4% over the five-year period. Since 2009, the Spanish market has grown by 21.4% each year on average. In 2021, Spain was in fifth place, with South Korea leading the way at $2.1 billion. Germany, Italy and South Korea took spots two, three and four respectively. The number of hospital discharges related to anemia in Spain is expected to reach 26,850 by 2026, up from 26,150 in 2021 – a rise of 0.5% year-on-year. Since 1985, the Spanish demand has increased by 0.5% annually. In 2021, Australia led the way at 26,150 hospital discharges while Germany, the United Kingdom and Poland took positions two, three and four respectively.